Marcus Lueger

Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic.

Aventis Pharma Deutschland GmbH produces pharmaceutical products. It offers prescription drugs, human vaccines, and therapeutic proteins businesses. Aventis Pharma Deutschland plans and designs plants and process control systems in the areas of active ingredients production and finished drugs. The company is headquartered in Frankfurt am Main, Germany.

Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany.

KfW IPEX-Bank GmbH provides project, corporate, trade and export finance services. It offers medium to long-term financing solutions to support the German and European economy. The firm finances economic and social infrastructure in Europe, helps to secure the supply of raw materials and supports the realization of environmental and climate protection projects - all over the world. It finances for ships, aircraft and railroad vehicles as well as for investments in the expansion of airports and seaports. The firm provides tailor-made financing solutions for energy and environmental protection projects. The company was founded in 1948 and is headquartered in Frankfurt, Germany.

Pensionskasse der Mitarbeiter der Hoechst-Gruppe VVaG is a German company that provides insurance services. The private company is based in Frankfurt, Germany. and has subsidiaries in Germany. Jürgen Rings has been the CEO of the company since 2018.

Part of Sanofi, Hoechst Trevira GmbH & Co. KG is a German company that provides financial services. The company is based in Frankfurt, Germany. The CEOs are Fabrizio Guidi, Evelyne Freitag. The company was founded in 1994.

Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland Investments GmbH develops and markets pharmaceutical products. The company is based in Berlin, Germany. The CEOs of the German company are Roland Kurney, Heidrun Irschik-Hadjieff.

Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland GmbH develops therapies for patients with rare and other specific diseases. The company is based in Berlin, Germany. The CEOs are Uwe Fröhlich, Heidrun Irschik-Hadjieff, Karsten Meisloch. The German company was founded in 1986.

Goodyear Dunlop Tires Germany GmbH manufactures and supplies car, truck, motorcycle and racing tires. Its product technologies encompass tread design, multi-blade system, bead seat system, multi-radius tread and flatter tread profile. The firm is engaged in tire and equipment development and management. The company was founded in 1888 and is headquartered in Hanau, Germany.

Part of Sanofi, Hoechst GmbH is a German company that manufactures and sells drugs. The company is based in Frankfurt, Germany. The CEO of the company is Fabrizio Guidi.

Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharma Vertrieb GmbH & Co. KG is a German company that sells pharmaceutical products. The company is based in Berlin, Germany. The CEOs are Roland Kurney, Heidrun Irschik-Hadjieff. The company was founded in 1781.

Part of Sanofi, Hoechst Trevira Verwaltungs GmbH is a German company that provides administration and management services. The company is based in Frankfurt, Germany. The CEOs are Fabrizio Guidi, Evelyne Freitag. The company was founded in 1994.

Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics.